The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic [4]

Martin W.I.M. Horstink, Baziel G. Van Engelen, Clifford W. Shults, Richard Haas, David Oakes, Karl Kieburtz, Sandra Plumb, Ira Shoulson, Roger Kurlan, M. Flint Beal, Jorge Juncos, Ray Watts, John Nutt, Julie Carter, Katie Kompoliti, Joel Perlmutter, Stephen Reich, Matt Stern, Eric Molho, Madeline HarrisonMark Lew

Research output: Contribution to journalLetter

27 Scopus citations
Original languageEnglish (US)
Pages (from-to)1170-1173
Number of pages4
JournalArchives of Neurology
Volume60
Issue number8
DOIs
StatePublished - Aug 1 2003

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology

Cite this

Horstink, M. W. I. M., Van Engelen, B. G., Shults, C. W., Haas, R., Oakes, D., Kieburtz, K., Plumb, S., Shoulson, I., Kurlan, R., Beal, M. F., Juncos, J., Watts, R., Nutt, J., Carter, J., Kompoliti, K., Perlmutter, J., Reich, S., Stern, M., Molho, E., ... Lew, M. (2003). The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic [4]. Archives of Neurology, 60(8), 1170-1173. https://doi.org/10.1001/archneur.60.8.1170-b